These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 17192788)

  • 41. p16INK4A as a marker for cervical dyskaryosis: CIN and cGIN in cervical biopsies and ThinPrep smears.
    Murphy N; Ring M; Killalea AG; Uhlmann V; O'Donovan M; Mulcahy F; Turner M; McGuinness E; Griffin M; Martin C; Sheils O; O'Leary JJ
    J Clin Pathol; 2003 Jan; 56(1):56-63. PubMed ID: 12499437
    [TBL] [Abstract][Full Text] [Related]  

  • 42. p16(INK4a) as a complementary marker of high-grade intraepithelial lesions of the uterine cervix. I: Experience with squamous lesions in 189 consecutive cervical biopsies.
    Dray M; Russell P; Dalrymple C; Wallman N; Angus G; Leong A; Carter J; Cheerala B
    Pathology; 2005 Apr; 37(2):112-24. PubMed ID: 16028838
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Expression of p16 INK4A in Papanicolaou smears containing atypical squamous cells of undetermined significance from the uterine cervix.
    Nieh S; Chen SF; Chu TY; Lai HC; Fu E
    Gynecol Oncol; 2003 Oct; 91(1):201-8. PubMed ID: 14529682
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Keratin 17 Is a Prognostic Biomarker in Endocervical Glandular Neoplasia.
    Mockler D; Escobar-Hoyos LF; Akalin A; Romeiser J; Shroyer AL; Shroyer KR
    Am J Clin Pathol; 2017 Sep; 148(3):264-273. PubMed ID: 28821199
    [TBL] [Abstract][Full Text] [Related]  

  • 45. p16 expression in primary ovarian mucinous and endometrioid tumors and metastatic adenocarcinomas in the ovary: utility for identification of metastatic HPV-related endocervical adenocarcinomas.
    Vang R; Gown AM; Farinola M; Barry TS; Wheeler DT; Yemelyanova A; Seidman JD; Judson K; Ronnett BM
    Am J Surg Pathol; 2007 May; 31(5):653-63. PubMed ID: 17460447
    [TBL] [Abstract][Full Text] [Related]  

  • 46. p16(INK4a) immunoprofiles of squamous lesions of the uterine cervix-implications for the reclassification of atypical immature squamous metaplasia.
    Skapa P; Robova H; Rob L; Zamecnik J
    Pathol Oncol Res; 2013 Oct; 19(4):707-14. PubMed ID: 23686439
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Intestinal-type endocervical adenocarcinoma in situ: an immunophenotypically distinct subset of AIS affecting older women.
    Howitt BE; Herfs M; Brister K; Oliva E; Longtine J; Hecht JL; Nucci MR
    Am J Surg Pathol; 2013 May; 37(5):625-33. PubMed ID: 23552379
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Endocervical adenocarcinoma in situ of tubal type and its relation to atypical tubal metaplasia.
    Schlesinger C; Silverberg SG
    Int J Gynecol Pathol; 1999 Jan; 18(1):1-4. PubMed ID: 9891235
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Study of p16(INK4A) expression and DNA ploidy in HPV-negative cervical cancers and precursors].
    Lin ZH; Liu MZ; Zhao YW; Wu QY; Liu SP; Kim I
    Zhonghua Bing Li Xue Za Zhi; 2006 Jul; 35(7):412-6. PubMed ID: 17069677
    [TBL] [Abstract][Full Text] [Related]  

  • 50. CD10 and calretinin staining of endocervical glandular lesions, endocervical stroma and endometrioid adenocarcinomas of the uterine corpus: CD10 positivity is characteristic of, but not specific for, mesonephric lesions and is not specific for endometrial stroma.
    McCluggage WG; Oliva E; Herrington CS; McBride H; Young RH
    Histopathology; 2003 Aug; 43(2):144-50. PubMed ID: 12877729
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Up-regulation of expression and lack of 5' CpG island hypermethylation of p16 INK4a in HPV-positive cervical carcinomas.
    Ivanova TA; Golovina DA; Zavalishina LE; Volgareva GM; Katargin AN; Andreeva YY; Frank GA; Kisseljov FL; Kisseljova NP
    BMC Cancer; 2007 Mar; 7():47. PubMed ID: 17359536
    [TBL] [Abstract][Full Text] [Related]  

  • 52. P16(INK4a) expression as a potential prognostic marker in cervical pre-neoplastic and neoplastic lesions.
    Queiroz C; Silva TC; Alves VA; Villa LL; Costa MC; Travassos AG; Filho JB; Studart E; Cheto T; de Freitas LA
    Pathol Res Pract; 2006; 202(2):77-83. PubMed ID: 16376485
    [TBL] [Abstract][Full Text] [Related]  

  • 53. p16 and Ki-67 immunostaining in atypical immature squamous metaplasia of the uterine cervix: correlation with human papillomavirus detection.
    Iaconis L; Hyjek E; Ellenson LH; Pirog EC
    Arch Pathol Lab Med; 2007 Sep; 131(9):1343-9. PubMed ID: 17824788
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A retrospective study on incidence, diagnosis, and clinical outcome of gastric-type endocervical adenocarcinoma in a single institution.
    Radomska A; Lee D; Neufeld H; Korte N; Torlakovic E; Agrawal A; Chibbar R
    Diagn Pathol; 2021 Jul; 16(1):68. PubMed ID: 34332600
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Distinction of endocervical and endometrial adenocarcinomas: immunohistochemical p16 expression correlated with human papillomavirus (HPV) DNA detection.
    Ansari-Lari MA; Staebler A; Zaino RJ; Shah KV; Ronnett BM
    Am J Surg Pathol; 2004 Feb; 28(2):160-7. PubMed ID: 15043304
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Stratification of HPV-induced cervical pathology using the virally encoded molecular marker E4 in combination with p16 or MCM.
    Griffin H; Soneji Y; Van Baars R; Arora R; Jenkins D; van de Sandt M; Wu Z; Quint W; Jach R; Okon K; Huras H; Singer A; Doorbar J
    Mod Pathol; 2015 Jul; 28(7):977-93. PubMed ID: 25953390
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Endocervical adenocarcinomas with prominent endometrial or endomyometrial involvement simulating primary endometrial carcinomas: utility of HPV DNA detection and immunohistochemical expression of p16 and hormone receptors to confirm the cervical origin of the corpus tumor.
    Yemelyanova A; Vang R; Seidman JD; Gravitt PE; Ronnett BM
    Am J Surg Pathol; 2009 Jun; 33(6):914-24. PubMed ID: 19295407
    [TBL] [Abstract][Full Text] [Related]  

  • 58. p16(INK4a) immunostaining in cytological and histological specimens from the uterine cervix: a systematic review and meta-analysis.
    Tsoumpou I; Arbyn M; Kyrgiou M; Wentzensen N; Koliopoulos G; Martin-Hirsch P; Malamou-Mitsi V; Paraskevaidis E
    Cancer Treat Rev; 2009 May; 35(3):210-20. PubMed ID: 19261387
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The prognostic impact of cyclin dependent kinase inhibitors p21WAF1, p27Kip1, and p16INK4/MTS1 in adenocarcinomas of the uterine cervix: an immunohistochemical evaluation of expression patterns in population-based material from 142 patients with international federation of gynecology and obstetrics stage I and II adenocarcinoma.
    Alfsen GC; Reed W; Sandstad B; Kristensen GB; Abeler VM
    Cancer; 2003 Nov; 98(9):1880-9. PubMed ID: 14584070
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Biomarker (ProEx C, p16(INK4A), and MiB-1) distinction of high-grade squamous intraepithelial lesion from its mimics.
    Pinto AP; Schlecht NF; Woo TY; Crum CP; Cibas ES
    Mod Pathol; 2008 Sep; 21(9):1067-74. PubMed ID: 18552822
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.